The lawsuit alleges the price increases EpiPen, used to treat severe allergic reactions, prevented other similar medications ...

The global injectable potassium phosphate market is witnessing remarkable growth, with sales projected to rise from USD 562.6 ...

Biopharma executives were busy Monday, striking high-value deals and providing updates on cancer, obesity and vaccine ...

Obesity continues to grab attention at the J.P. Morgan Healthcare Conference in San Francisco, with both Pfizer and Kailera ...

Welcome to day 1 of the J.P. Morgan Healthcare Conference, the industry's most significant dealmaking event each year.  | For ...

CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in ...

U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that ...

Middle East and Asia Injectable Drugs market 2025 To achieve a therapeutic effect in humans and animals, drug delivery is the method of delivering a Pharmaceutical compound. Mr. Shah Coherent Market ...

PF-07940369 is under clinical development by Pfizer and currently in Phase I for Anemia. According to GlobalData, Phase I drugs for Anemia have an 80% phase transition success rate (PTSR) indication ...

Debapratim Das, Professor at IIT-Guwahati's Department of Chemistry, said cancer continues to affect millions of patients worldwide but current treatments such as chemotherapy and surgical ...

But if you don’t, and you’ve considered using Botox or fillers, you’re probably wondering how to kick off your injectables journey and how to get the best results. Those are questions that we — Raj ...

Pfizer gave Sangamo Therapeutics coal for Christmas, terminating a hemophilia A gene therapy pact to deprive the cash-strapped biotech of up to $220 million in milestones. Pfizer’s decision sent ...